Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -738,822 | -593,267 | -419,824 | -221,677 | -846,422 |
| Depreciation Amortization | 9,922 | 7,349 | 4,224 | 2,246 | 7,855 |
| Accounts payable and accrued liabilities | -6,386 | -538 | 1,599 | 91 | 710 |
| Other Working Capital | 1,357 | 11,182 | 14,193 | -4,365 | 16,811 |
| Other Operating Activity | 124,491 | 96,498 | 66,748 | 58,581 | 238,593 |
| Operating Cash Flow | $-609,438 | $-478,776 | $-333,060 | $-165,124 | $-582,453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -715 | -707 | -694 | -461 | -4,049 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 391 |
| Purchase Of Investment | -266,875 | -178,144 | -178,144 | -44,660 | -745,680 |
| Sale Of Investment | 570,000 | 495,000 | 330,000 | 210,000 | 504,364 |
| Other Investing Activity | -1,849 | -1,849 | -1,829 | 0 | 0 |
| Investing Cash Flow | $300,561 | $314,300 | $149,333 | $164,879 | $-244,974 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250,000 | 250,000 | 250,000 | N/A | N/A |
| Common Stock Issued | 191,008 | 0 | 0 | N/A | 677,666 |
| Other Financing Activity | -1,891 | 321 | 199 | 369 | 108 |
| Financing Cash Flow | $439,117 | $250,321 | $250,199 | $369 | $677,774 |
| Exchange Rate Effect | -3 | -3 | -17 | 23 | 75 |
| Beginning Cash Position | 102,542 | 102,542 | 102,542 | 102,542 | 252,120 |
| End Cash Position | 232,779 | 188,384 | 168,997 | 102,689 | 102,542 |
| Net Cash Flow | $130,237 | $85,842 | $66,455 | $147 | $-149,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | -609,438 | -478,776 | -333,060 | -165,124 | -582,453 |
| Capital Expenditure | -715 | -707 | -694 | -461 | -4,049 |
| Free Cash Flow | -610,153 | -479,483 | -333,754 | -165,585 | -586,502 |